Genes associated with multiple sclerosis: 15 and counting

Expert Review of Molecular Diagnostics

Volumn 10, Issue 7, 2010, Pages 857-861

  Habek, Mario ^a,b,c   Brinar, Vesna V ^b,c   Borovečki, Fran ^a,b,d  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

^c Referral Center for Demyelinating Diseases of the Central Nervous System   (Croatia)

^d Center for Translational and Clinical Research   (Croatia)

Author keywords

genetics; genome wide association study; IL12A; MPHOSPH9CDK2AP1; multiple sclerosis; RGS1

Indexed keywords

HLA DRB1 ANTIGEN;

ALLELE; ARTICLE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HUMAN; MULTIPLE SCLEROSIS;

EID: 79952995197     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.10.77     Document Type: Article

References (36)

1. Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science 278, 1580-1581 (1997). (Pubitemid 27516268)
2. Kere J. Genetics of complex disorders. Biochem. Biophys. Res. Commun. 396, 143-146 (2010).
3. International HapMap Consortium. The International HapMap Project. Nature 426(6968), 789-796 (2003).
4. Hindorff LA, Sethupathy P, Junkins HA et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA 106, 9362-9367 (2009).
5. Manolio TA, Collins FS, Cox NJ et al. Finding the missing heritability of complex diseases. Nature 461, 747-753 (2009).
6. Doolittle TH, Myers RH, Lehrich JR et al. Multiple sclerosis sibling pairs: clustered onset and familial predisposition. Neurology 40, 1546-1552 (1990). (Pubitemid 20351347)
7. Bobowick AR, Kurtzke JF, Brody JA, Hrubec Z, Gillespie M. Twin study of multiple sclerosis: an epidemiologic inquiry. Neurology 28(10), 978-987 (1978). (Pubitemid 8401526)
8. Jersild C, Svejgaard A, Fog T. HL-A antigens and multiple sclerosis. Lancet 1(7762), 1240-1241 (1972).
9. Kellar-Wood HF, Wood NW, Holmans P, Clayton D, Robertson N, Compston DA. Multiple sclerosis and the HLA-D region: linkage and association studies. J. Neuroimmunol. 58, 183-190 (1995).
10. Olerup O, Hillert J. HLA class IIassociated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38(1), 1-15 (1991).
11. The International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357, 851-862 (2007).
12. Comabella M, Craig DW, Camiña-Tato M et al. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS ONE 3, e3490 (2008).
13. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 41, 824-828 (2009).
14. The International Multiple Sclerosis Genetics Consortium (IMSGC). Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum. Mol. Genet. 19, 953-962 (2009).
15. De Jager PL, Jia X, Wang J et al. Metaanalysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 41(7), 776-782 (2009).
16. Oksenberg JR, Baranzini SE. Multiple sclerosis genetics-is the glass half full, or half empty? Nat. Rev. Neurol. 6(8), 429-437 (2010).
17. Bush WS, Sawcer SJ, de Jager PL et al. The International Multiple Sclerosis Genetics Consortium (IMSGC). Evidence for polygenic susceptibility to multiple sclerosis-the shape of things to come. Am. J. Hum. Genet. 86(4), 621-625 (2010).
18. The International Multiple Sclerosis Genetics Conssortium (IMSGC). IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun. 11(5), 397-405 (2010).
19. International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 449(7164), 851-861 (2007).
20. Dixon AL, Liang L, Moffatt MF et al. A genome-wide association study of global gene expression. Nat. Genet. 39(10), 1202-1207 (2007). (Pubitemid 47482680)
21. Bansal G, Druey KM, Xie Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol. Ther. 116(3), 473-495 (2007). (Pubitemid 350116944)
22. Moratz C, Hayman JR, Gu H, Kehrl JH. Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/-mice. Mol. Cell. Biol. 24(13), 5767-5775 (2004). (Pubitemid 38787962)
23. Agenes F, Bosco N, Mascarell L, Fritah S, Ceredig R. Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naive and regulatory T cells. Immunology 115(2), 179-188 (2005). (Pubitemid 40733403)
24. Amundsen SS, Rundberg J, Adamovic S et al. Four novel coeliac disease regions replicated in an association study of a Swedish-Norwegian family cohort. Genes Immun. 11(1), 79-86 (2010).
25. Smyth DJ, Plagnol V, Walker NM et al. Shared and distinct genetic variants in Type 1 diabetes and celiac disease. N. Engl. J. Med. 359(26), 2767-2777 (2008).
26. Kang BY, Kim E, Kim TS. Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells. Cell Signal. 17, 665-673 (2005). (Pubitemid 40259713)
27. Hinks A, Martin P, Flynn E et al. Investigation of Type 1 diabetes and coeliac disease susceptibility loci for association with juvenile idiopathic arthritis. Ann. Rheum. Dis. DOI:10.1136/ard.2009.126938 (2010).
28. Liu X, Invernizzi P, Lu Y et al. Genomewide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat. Genet. 42(8), 658-660 (2010).
29. Kim Y, McBride J, Kimlin L, Pae EK, Deshpande A, Wong DT. Targeted inactivation of p12, CDK2 associating protein 1, leads to early embryonic lethality. PLoS ONE 4(2), e4518 (2009).
30. De Jager PL, Chibnik LB, Cui J et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol. 8(12), 1111-1119 (2009).
31. Sawcer S, Ban M, Wason J, Dudbridge F. What role for genetics in the prediction of multiple sclerosis? Ann. Neurol. 67, 3-10 (2010).
32. Li B, Leal SM. Discovery of rare variants via sequencing: implications for the design of complex trait association studies. PLoS Genet. 5(5), e1000481 (2009).
33. Siva N. 1,000 genomes project. Nat. Biotechnol. 26, 256 (2008).
34. McCarroll SA, Altshuler DM. Copynumber variation and association studies of human disease. Nat. Genet. 39(7 Suppl.), S37-S42 (2007). (Pubitemid 47014474)
35. Redon R, Ishikawa S, Fitch KR et al. Global variation in copy number in the human genome. Nature 444(7118), 444-454 (2006). (Pubitemid 44809057)
36. Grozeva D, Kirov G, Ivanov D et al. Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch. Gen. Psychiatry 67(4), 318-327 (2010).